RxDoctor Payments Data

Maria Fernandez Blanes

Family · Miami, FLNPI 1124570718

Payments from drug & device makers

$855in general payments, 2019–2025

Across 44 payments — averaging $19.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$192
  • Exact Sciences$165
  • Amgen$105
  • Novartis$96
  • Bayer$82
  • AbbVie$77
  • plus $138 from 5 others

What the payments were for

  • Food & beverage$855100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$855 in reported general payments places this provider in the 65th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$46,970
Medicare patients
71
Services billed
558

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban62$39,188
OzempicSemaglutide31$34,113
VascepaIcosapent Ethyl64$22,195
GlyxambiEmpagliflozin/Linagliptin26$20,838
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$19,056
LinzessLinaclotide29$17,330
KerendiaFinerenone13$9,914
FarxigaDapagliflozin Propanediol12$7,295
MyrbetriqMirabegron14$6,433
Tresiba Flextouch U-100Insulin Degludec13$5,199
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog18$5,133
Diclofenac Sodium120$2,542
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate12$1,900
Megestrol Acetate33$1,884
Celecoxib15$1,772

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$20$39,18862 claims
Novo NordiskOzempic, Levemir$29$35,42243 claims
GSKTrelegy Ellipta$192$19,05630 claims
AbbVieLinzess$77$17,33029 claims
BayerKerendia$82$9,91413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 14,618 family providers in Florida.

Other family in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →